Moran, Claus Aagaard Nielsen, Mikkel Due Petersen, Lars Nygaard, David rsted, Christian Poulsen, Tina Secher Rasmussen, and Else Marie Agger (Novo Nordisk A/S, Denmark) for review of and input to the manuscript, and to Alexander Jones, PhD, CMPP TM and Sola Neunie, MSc, CMPP TM from AXON Communications (supported by Novo Nordisk) for writing assisstance
Water can help a little
(30) These findings suggest that semaglutide may play a role in reducing surgical-site infections and improving recovery outcomes by addressing key metabolic risk factors such as obesity, hyperglycemia, and systemic inflammation
Currently, preclinical studies examining the impact of semaglutide on bone metabolism are limited
A smooth Particle Mesh Ewald method
The sample was centrifuged at 160,000 g for 35 min and the supernatant was incubated with 1 mL TALON resin (Clontech) and 20 mM imidazole overnight at 4 C